Literature DB >> 21421327

Community-level socioeconomic inequalities in infants with poor fetal growth in Western Australia, 1984 to 2006.

Amanda T Langridge1, Jianghong Li, Natasha Nassar, Fiona J Stanley.   

Abstract

PURPOSE: This study describes social and racial inequalities in poor fetal growth in Western Australia between 1984 and 2006.
METHODS: Multilevel multivariate logistic regression was used to investigate relative differences in fetal growth restriction between socioeconomic groups. Fetal growth restriction was defined as having a proportion of optimal birth weight corresponding to less than the 10th percentile for the population. Aboriginal (N = 50,395) and non-Aboriginal (N = 517,073) infants were analyzed separately.
RESULTS: There has been an overall decrease in the rate of poor fetal growth during the last 23 years, with a plateau reached in recent years. Aboriginal infants were significantly more likely to have fetal growth restriction than non-Aboriginal infants and social inequalities increased over time, particularly among non-Aboriginal infants. After stratifying by Aboriginality and accounting for important parental sociodemographic characteristics, the community-level socioeconomic gradient remained.
CONCLUSIONS: This study highlights the misleading nature of observing aggregated rates of poor fetal growth that mask increasing inequalities, and the importance of monitoring trends by social and racial characteristics. It also highlights the concerning finding that almost all improvements in poor fetal growth have occurred in the least disadvantaged communities, with almost no change in the most disadvantaged communities, which is likely to result in further increases in social and racial inequalities.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21421327     DOI: 10.1016/j.annepidem.2011.02.009

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  6 in total

1.  Socioeconomic status accounts for rapidly increasing geographic variation in the incidence of poor fetal growth.

Authors:  Stephen J Ball; Peter Jacoby; Stephen R Zubrick
Journal:  Int J Environ Res Public Health       Date:  2013-06-25       Impact factor: 3.390

2.  What factors contribute to positive early childhood health and development in Australian Aboriginal children? Protocol for a population-based cohort study using linked administrative data (The Seeding Success Study).

Authors:  Kathleen Falster; Louisa Jorm; Sandra Eades; John Lynch; Emily Banks; Marni Brownell; Rhonda Craven; Kristjana Einarsdóttir; Deborah Randall
Journal:  BMJ Open       Date:  2015-05-18       Impact factor: 2.692

3.  Aboriginal birth cohort (ABC): a prospective cohort study of early life determinants of adiposity and associated risk factors among Aboriginal people in Canada.

Authors:  Gita Wahi; Julie Wilson; Ruby Miller; Rebecca Anglin; Sarah McDonald; Katherine M Morrison; Koon K Teo; Sonia S Anand
Journal:  BMC Public Health       Date:  2013-06-25       Impact factor: 3.295

4.  Are preterm birth and intra-uterine growth restriction more common in Western Australian children of immigrant backgrounds? A population based data linkage study.

Authors:  Ifrah Abdullahi; Kingsley Wong; Emma Glasson; Raewyn Mutch; Nicholas de Klerk; Jenny Downs; Sarah Cherian; Helen Leonard
Journal:  BMC Pregnancy Childbirth       Date:  2019-08-09       Impact factor: 3.007

5.  Association Between Iatrogenic Delivery for Suspected Fetal Growth Restriction and Childhood School Outcomes.

Authors:  Roshan John Selvaratnam; Euan Morrison Wallace; Rory Wolfe; Peter John Anderson; Mary-Ann Davey
Journal:  JAMA       Date:  2021-07-13       Impact factor: 56.272

6.  No improvement in socioeconomic inequalities in birthweight and preterm birth over four decades: a population-based cohort study.

Authors:  Svetlana V Glinianaia; Rakesh Ghosh; Judith Rankin; Mark S Pearce; Louise Parker; Tanja Pless-Mulloli
Journal:  BMC Public Health       Date:  2013-04-15       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.